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Abstract   
Background:  Anemia, defined as a decreased concentration of blood hemoglobin, is a 
major public health problem in persons living with HIV /AIDS particularly in people 
taking antiretroviral therapy (ART). Anemia in HIV/AIDS patient has effect on their 
quality of life and disease progression to AIDS. Studies regarding anemia among 
HIV/AIDS patients taking ART and its associated factors are scarce in Ethiopia society  
Objective: The aim of this study was to determine prevalence of Anemia and its 
associated factors among adult PLWHA who are taking antiretroviral therapy in Debre 
Tabor Hospital, Northwest Ethiopia, 2015 
Methods: A Hospital based Cross-Sectional quantitative study was employed in Debre 
Tabor Hospital from January 1, 2010-December 30, 2014.Simple random sampling 
technique was used; the total sample size was 385. 
Data was extracted from patient’s chart by using structured checklist. It was entered 
using EPI INFO version 7.1 and analyzed by using SPSS version 20. Both descriptive 
and Analytic statistics were carried out. Bivariate and multivariable logistic regression 
analysis was also made. Variables with P value < 0.05 were considered significant in 
multivariable Analysis.  
Results: A total of 377 patients chart were reviewed, the overall prevalence of anemia 
was 23.1% (95% CI: 19.1, 27.6). The multivariable analysis showed that ART naïve 
patients (AOR=3.37, 95% CI: 1.59, 7.14), Zidovudine containing regimen (AOR=2.14, 
95% CI: 1.03, 4.57), anti tuberculosis drugs (AOR=3.21, 95% CI: 1.19, 8.67) and                           
Cluster of Differentiation 4 (CD4) count of < 200 cells/mm3 (AOR=2.13, 95% CI: 1.04, 
4.36) were significantly associated with occurrence of anemia. 
Conclusions: The prevalence of anemia was moderate and found to be public health 
problem. Duration of ART, type of ART drugs, anti TB drugs and CD4 count 
 < 200 cells/mm3 was significantly associated with occurrence of anemia. 
Recommendation: Early diagnosis and treatment of anemia is recommended for 
 HIV /AIDS patients taking ART. 
Keywords: HIV, AIDS, Anemia, Antiretroviral therapy, Debretabor hospital 
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1. Introduction 
1.1Statement of the problem  
Anemia is defined as a hemoglobin level <12 gm/dl for adult female and <13 gm/dl for 
adult male (1).Anemia is a global health problem in both developing and developed 
countries with major consequences on human health as well  as social and economic 
development (2). Globally, anemia affects 1.62 billion people, which corresponds to 
24.8% of the population (2). It is the most common Hematologic abnormalities in 
patients with HIV infection and those taking antiretroviral therapy (3). It occurs  at  any  
stage of  HIV infection  and  its  prevalence  and  severity  are  correlated  with 
progression  of  the  disease (4). The prevalence is about 28% among people with HIV 
infection and 71% in those with AIDS respectively (5)  
Prevalence of Anemia among adult HIV/AIDS patients taking ART ranging from 23-50% 
in worldwide (6, 7) and 24-58% in Africa (8, 9). Anemia among adult HIV/AIDS patients 
taking ART in Ethiopia is a common problem, with a prevalence ranging from 11.5%- 
35% (10, 11)  
The cause of anemia in patients with HIV infection are blood loss, neoplastic disease, 
opportunistic infection, low CD4 count ,high viral load, use of myelosuppressive 
medications,HIV infection per se, a decreased production of endogenous erythropoietin, 
nutritional deficiencies and Increased RBC destruction( hemolysis) (12) 
Anemia in HIV/AIDS patients cause fatigue, pale skin, shortness of breath, dizziness 
and other symptoms associated with impaired physical functioning, psychological 
distress, and decrements in quality of life, increases HIV disease  progression and  
leads to shorter life expectancy (12) 
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Management of anemia in HIV/AIDS patients taking ART has been shown to improve 
survival and quality of life. Getting treatment for anemia is very important and the type of 
treatment will depend on the cause or type of anemia (13) 
Appropriate diagnosis and management of anemia for HIV/AIDS patients is important 
public heath measure .Hence the current study was determine the prevalence of 
anemia and associated factors in people living with HIV. 
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1.2. Literature review  
1.2.1.Prevalence of Anemia among adult PLWHA taking ART 
Studies done at different countries suggested that anemia is a major public health 
problem in PLWHA.  A study done in India on ART indicates that anemia has been 
reported in 23% of all patients (6). A study conducted in Indonesia showed that the 
prevalence of anemia was found in 49.6% of ART naïve patient (7). A study conducted 
in Uganda showed that the prevalence of anemia among HIIV/AIDS patients taking ART 
was 47.8% (14). 
A study done in Ghana revealed the incidence of anemia as 63% in ART-naïve patients 
and 46% on ART patients (8) .A study conducted in Nigeria indicated that the incidence 
of anemia was 57.5% in ART-naive patients, it was significantly higher than their 
counterparts on ART which was 24.3% (9).  
A retrospective cohort study done on Incidence and risk factors of anemia among 
HIV/AIDS patients taking ART at tertiary hospitals in Addis Ababa, Ethiopia indicated 
that the overall incidence of anemia was 35.3% (15) 
Health Facility-based study conducted in Jimma University specialized hospital showed 
that, the overall prevalence of anemia was (23.1%), as well the prevalence of anemia in 
ART naive and ART experienced persons was 29.9% and 16.2%, respectively (16) 
 
A study conducted in University of Gonder Hospital, the overall prevalence of anemia in 
ART experienced patients ranged from 11.5%-35% (10, 11) 
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1.2.2.Factors associated with Anemia among adult PLWHA taking 
ART 
1.2.2.1.Sociodemographic factors  
Different studies documented that sex is significantly associated with anemia among 
HIV/AIDS patients taking HAART. Studies conducted in South Africa (17) , Namibia 
(18), University of Gonder Hospital, Ethiopia (19) showed that females were significantly 
associated with occurrence of anemia than males. Whereas a study conducted in 
Nigeria (20) and Hawassa university referral hospital (21), Ethiopia showed that male 
patients had higher chance of being anemic than females  
In a study conducted at Jimma University hospital, South west Ethiopia ,among 
HIV/AIDS patients taking ART, anemia was prevalent in rural residents (16)  
A study conducted in University of Gondar Hospital, Northwest Ethiopia among 
HIV/AIDS patients taking ART indicates that the odds of anemia among  divorced  and 
widowed  participants were 2.3 times and  3.1  times respectively as compared  to 
married  counter  parts (19) 
A study at University of Gondar Hospital, showed that anemia was higher in illiterate 
patients as compared with those who completed secondary  education. In this study 
patients who were earning < 500 birr  were more  likely to develop anemia as compared 
to those earning > 500 birr (19)  
1.2.2.2. Medication related factors  
Different studies showed that duration of ART had significantly associated with anemia 
among HIV/AIDS patients taking ART. Studies conducted in Ghana (8), South Africa 
(17), and a cohort study in Namibia (18) showed that ART-naïve patients are at higher 
risk of developing anemia compared to patients on ART experienced groups 
Studies documented that ART regimen has significant associated with anemia among 
HIV/AIDS patients taking ART. Studies conducted in Indonesia (7), Iran (22), Namibia 
(18) and Ethiopia (15) showed that ZDV containing regimen was significantly associated 
with anemia compared to non ZDV based regimes.  
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A study conducted in India the incidence of anemia was higher in HIV-infected patients 
treated with Anti TB drugs compared with those  not treated with Anti TB drugs (23) 
1.2.2.3. Co morbidities  
Studies conducted in different areas among HIV/AIDS patient taking ART showed that 
presence of opportunistic infections is significantly associated with anemia. A study 
conducted among HIV/AIDS patient taking ART in Uganda (14) and Ethiopia (15, 16) 
showed that presence of opportunistic infections were significantly associated with 
anemia 
1.2.2.4. WHO HIV Staging  
A study conducted in South Africa among HIV infected patients initiating ART showed 
that advanced HIV disease was associated with increased incidence of anemia over the 
follow-up period (17) 
1.2.2.5. Hematological related factors  
Different studies documented that low CD4 count is associated with anemia among 
HIV/AIDS patients taking ART. A study conducted in Mexico (24), South Africa (17), 
Namibia (25) and Ethiopia showed that CD4 count <200 cells/µl is significantly 
associated with anemia  
A cross-sectional analytical study conducted in Mexican population among HIV/AIDS 
patients taking ART showed that WBC (white blood cell) <4,000 cells/mm and platelets 
<200,000 cells/mm were associated with anemia (24)  
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CONCEPTUAL FRAMEWORK  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1: Conceptual frame work of anemia among adult PLWHA patients taking ART 
and its associated factors  
 Source: Developed by the principal investigator by reviewing different literatures  
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1.3  Justification of the study 
Anemia is the most common hematological finding in patients with HIV infection, 
particularly in individuals with more advanced HIV disease in developing country. The 
presence of anemia in HIV/AIDS patients taking ART associated with faster disease 
progression and then decreases the quality of life and survival rate of HIV patients. 
Recovery from anemia is associated with decreased risk of death. 
Knowing correction of anemia leads to improved quality of life and decreases in 
morbidity and mortality in HIV-infected patients taking ART, studies on the prevalence of 
anemia in HIV infected patients taking ART and its associated factors has not been very 
well understood in the study area 
Therefore, the aims of this study investigate prevalence and associated factors of 
anemia among adult PLWHA taking ART.  
The result of the study will help policy makers, stakeholders, responsible persons in the 
health institution, and significant others to take actions 
  
 
 
 
 
 
 
 
. 
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2.  Objectives 
2.1. General objective 
 To determine prevalence of Anemia and its associated factors among adult 
people living with HIV/AIDS who were on ART in Debre Tabor Hospital, 
Northwest Ethiopia. 
2.2. Specific objectives  
 To determine prevalence of anemia among adult people living with HIV/AIDS 
who were on ART. 
 To identify factors associated with anemia among adult people living with 
HIV/AIDS who were on ART. 
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3. Methods 
3.1. Study design and period 
Hospital based cross-sectional quantitative study was employed. The study period was 
from April- May, 2015. 
3.2. Study area 
The study was conducted at Debre Tabor General Hospital. The hospital is located in 
Northwest Ethiopia, Amhara National Regional State, in Debre Tabor town 665 km from 
the country capital. Currently the hospital has catchment population of about 2.3 million 
serving as General hospital for all population in the zone and nearby woredas. It has 
capacity of 91 beds for inpatient with five disciplines (Surgery, Internal medicine, 
pediatrics, Gynecology/Obstetrics and neonatology) with 12 outpatient department 
(OPDs). 
One of the service that the hospital deliver is ART and follow up for HIV/AIDS patients 
and serves about 20-30 HIV/AIDS patients per day at ART clinic  during working hours.  
3.3. Source and study population  
3.3.1. Source population 
The source populations were all adult PLWHA who were taking antiretroviral 
therapy at Debretabor Hospital in Debre Tabor Town of South Gondar 
Administrative Zone.  
3.3.2. Study population  
The study populations were all adult PLWHA who were on ART in Debre Tabor 
Hospital, from January 1, 2010-December 30, 2014. 
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3.4. Inclusion and exclusion criteria 
3.4.1. Inclusion criteria 
 All adult people living with HIV/AIDS age >15 years who were taking ART in 
Debre Tabor hospital from January 1, 2010-December 30, 2014. 
3.4.2. Exclusion criteria 
 Those HIV/AIDS patients who were on ART with missing hemoglobin results on 
the chart, either at baseline or during follow-up. 
 Pregnant  women  and  women  in  the  post-partum  period  (within  6  weeks  
post delivery 
  Anemic patients at ART  initiation     
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3.5 Sample size & sampling procedures  
3.5.1. Sample size determination 
The sample size was calculated by using single population proportion formula. 
                     n = (Z/2 )
2 p(1-p) 
 d2 
n = (1.96)2 (0.35)(1-0.35)     =350 
      (0.05)2 
 
Where  
n=Estimated sample size 
P= Single population proportion (35%) =>proportion of anemia in adult PLWHA 
who were taking ART(10). 
Z/2 = value of standard normal distribution (Z-statistic) at the 95% confidence level 
(= 0.05) which is 1. 96,  
d= Margin of error 5% (0.05);  
       10% = a contingency for incomplete data 
       The total sample size of the study population was 385 
Sampling for some independent variables by using EPI INFO stat calc.(19)  
Variable name  Proportion of anemia  (P) OR n Assumption  
Female sex 70.3 0.74 146 CI=95%  
Power=80% 
Ratio 1:1  
Income < 500 
ETB 
65.8 0.51 348 
HAART users  75.8 0.7 204 
 
Since the sample size for the above explanatory variables are less than the sample size 
of the outcome variable (anemia) I took the sample size of the outcome variable. 
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3.5.2. Sampling procedures 
Simple  random  sampling  technique  was  used  to  obtain predetermined  sample  
size  from  the  ART clinic  computerized  register.  
First the total of 686 patient charts registration number was identified and written on 
SPSS version 20,385 charts were selected by using computer generated (SPSS 
selection cases) method among adult PLWHA taking ART charts.  
3.6 Operational definitions  
 Anemia is defined as a hemoglobin level <12 g/dl for adult female and <13 g/dl 
for adult male, in accordance with WHO guideline. 
 ART naive patients defined as HIV-infected patients who were taking  ART for ≤ 
6 months where as ART users(experienced) patients defined as HIV-infected 
patients who were taking  ART for >6 months 
 WHO  HIV/AIDS  clinical  staging  was  defined  as  the  clinical  grade  of  the  
adult participant  at  ART  initiation  according  to  the  WHO  clinical  staging  
guideline (grade 1 to 4) 
3.7 Variables 
Dependent variable 
 Anemia (Presence or Absence) 
Independent variables 
 Socio-Demographic  
 Age (years), Sex, Residence, Ethnic group, Religion, Marital status, Educational 
Status, occupational status ,Monthly income 
 Medication related  factors  
 Duration of HAART usage 
 Type of drug 
 History of opportunistic infection  
 WHO stage  
 Hematologic parameter  
 CD4 count, Platelet count, WBC count 
13 
 
3.8. Data collection tool 
A structured checklist, in English languages was used to collect data. Hemoglobin 
measurements (hemoglobin level <12 gm/dl for adult female and <13 gm/dl for adult 
male), was obtained from the patients charts by reviewing the selected charts from 
January 1, 2010-December 30, 2014. 
It was designed to seek information pertaining to socio-demographic characteristics 
(age, sex, marital status, employment, educational level etc), OI, WHO Stage, 
hematologic parameters, medication related factors, measurements, and presence of 
anemia. 
3.9. Data quality control 
The checklist was pre-tested through a random selection of 5% of the charts of 
HIV/AIDS patients who were taking ART from Debretabor Health center to assess 
whether the checklist items was easily understood by data collector. Careful 
modification of the checklist was done; before the main study was begin.  
Three data collectors and one supervisor were recruited for the data collection, and 
training was given for 2 days, regarding the research tool and how to collect data from 
patient chart. Information exchange by telephone and close supervision by the principal 
investigator and supervisor was made on a daily basis in order to correct problems 
during the course of the data collection time, frequent checking of information collected 
for errors, missing values and its consistency in order to set right daily. Coding and data 
cleaning was done 
3.10. Data processing and analysis 
Data was entered using EPI INFO version 7.1 and was checked and cleaned for 
completeness and consistency of values and variables. Data were export to Statistical 
Package for the Social Sciences /SPSS/ version 20 for further analysis, through 
checking missing values, computing calculable variables & recoding.  
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Descriptive statistics were done using statistical measurements. Frequency, 
percentages, means, standard deviations, finally tables and graphs was used to report 
findings. Bivariate analysis was done to check which variables have associations with 
anemia. Variables found to have p-values up to 0.2 was fitted in multivariable logistic 
regression for controlling the possible effects of confounders and finally the variables 
which have significant association with the outcome variable were identified on the 
basis of OR, 95% CI, p-values <0.05 and Hosmer-Lemeshow goodness of test for the 
model was also checked. 
4.  Ethical considerations 
Ethical clearance was obtained from Institutional Ethical Review Board (IERB), Institute 
of Public Health, University of Gondar. Permission letter was obtained from Debre 
Tabor Hospital Chief Executive officer. 
5. Dissemination and utilization of results  
The results of the study will be presented to University of Gondar, College of medicine 
and health sciences, Institute of Public Health and Internal medicine as partial fulfillment 
criteria for master of clinical tropical infectious disease and HIV medicine & it will be also 
getting share to ARSHB, South Gondar zone Health office and Debre Tabor hospital 
administrations. Efforts will also be made to present the results on scientific 
conferences; and also the results will be disseminated through publication in local or 
international journal  
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6. Result  
A total of 377 (97.9%) patients chart were reviewed out of 385 patients chart .Eight of 
them were excluded due to incompleteness. 
Socio demographic characteristics 
From the total patients 234 (62.1%) were females and the mean age was 35.21 (SD± 
9.27) years which ranges from 17 - 71 years. Three hundred seventy five (99.5%) were 
Amhara ethnic group and 367 (97.3%) were orthodox Christian. From the total patients 
291 (77.2%) were urban resident, 191 (50.5%) were married, 111 (29.4%) were Unable 
to read and write and 100 (26.5%) were civil servant. (Table 1) 
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Table 1:-Socio demographic characteristics of Anemia among PLWHA taking ART in 
Debre Tabor Hospital, Northwest Ethiopia, June 2015 (n=377) 
Variable                Category  Frequency  percent 
  Sex                      Male  
                              Female 
143 
234 
37.9 
62.1 
   
 Age                       15-29 
                               30-39 
                               40-49 
                                 ≥50 
 
  92                                                                 
170 
  87 
  28 
 
24.4
45.1 
23.1 
  7.4 
 
Ethnic group         Amhara 
                               Tigre 
 
375 
    2 
 
99.5 
  0.5 
 
Residence              Urban  
                                Rural 
 
291 
  86 
 
77.2 
22.8 
 
Religion                  Orthodox 
                                Muslim 
                                Protestant  
 
367 
    9 
    1 
 
97.3 
   2.4 
   0.3 
 
Marital status         Single 
                                Married 
                                Divorced 
                                Widowed  
                                Separated 
   
  76 
191 
  37 
  59 
  14 
 
20.2 
50.7 
  9.8 
15.6 
  3.7 
Educational status  
   Unable to read and write 
    Read and write 
    Primary school 
    Secondary school 
    College/university  
 
111 
  24 
  92 
  80 
  70 
 
29.4 
  6.4 
24.4 
21.2 
18.6 
Occupational status 
Civil servant 
Daily laborer 
Merchant 
House wife 
Retired 
Farmer 
Student 
Unemployed 
Other* 
 
100 
  41 
  55 
  90 
    3 
  42 
  19   
  10 
  17 
 
26.5 
10.9 
14.6 
23.9 
  0.8 
11.1 
  5.0 
  2.7 
  4.5 
Others*: sex workers, carpenter, shop keeper, waiter and garage worker. 
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Medication Related factor  
From the total participants 112 (29.7%) were taking AZT containing ART regimen and 
140 (37.1%) were ART naïve patients (figure 2) 
 
Figure 2: Medication related factors of anemia among adult PLWHA taking ART in 
Debre Tabor Hospital, Northwest Ethiopia, June 2015 (n=377) 
Co morbidity and WHO stage Factor 
From the total participants 191 (50.7%) have had opportunistic infections  
 
Figure 3: WHO stage factor of anemia among adult PLWHA  taking ART in Debre Tabor 
Hospital, Northwest Ethiopia, June 2015 (n=377) 
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Hematological and Physical Measurement Factor 
From the total participants 126 (33.4%), 73 (19.4%) and 76 (20.2%) have had CD4 
count of <200 cells/mm3, WBC count of <4000 cells/mm3 and platelet count of < 
200,000cells/mm3 respectively. 
Regarding their BMI 281 (74.5%) of the total participant were normal (Table 2) 
Table 2:-Body mass index factors of Anemia among adult PLWHA taking ART in Debre 
Tabor Hospital, Northwest Ethiopia, June 2015 (n=377) (Table 2)  
Variable  Frequency  Percent  
BMI 
      Under weight  
      Normal 
      Over weight  
      Obesity 
 
82 
281 
13 
1 
 
21.8 
74.5 
  3.4 
  0.3 
 
Prevalence of Anemia among adult PLWHA patients taking ART 
The overall prevalence of anemia among adult PLWHA taking ART was 23.1% (95% CI: 
19.1, 27.6). The prevalence of anemia among adult male PLWHA taking ART was 
37.9% and female adult PLWHA taking ART was 62.1%. 
 Factors Associated with Anemia  
The association of selected socio demographic, medication related factor, co morbidity, 
hematological related factors and physical measurement on anemia were investigated 
by using both the bivariate and multi variable logistic regression techniques. Those 
variables with a P value up to 0.2 in bivariate analysis were included in the multi 
variable analysis. As a result, types of ART drugs, anti TB drugs, duration of ART usage 
and CD4 count were significantly associated with anemia. 
In this study, HIV/AIDS Patients who were ART naïve were three times (AOR=3.37, 
95% CI: 1.59, 7.14) more likely to develop anemia as compared to ART users. Those 
patients who were taking AZT containing regimen were two times (AOR=2.14, 95% CI: 
1.03, 4.57) higher to develop anemia as compared to not taking AZT containing 
regimen. 
19 
 
HIV/AIDS Patients who were taking ART and those who took anti TB drugs were three 
times (AOR=3.21, 95% CI: 1.19, 8.67) more likely to develop anemia as compared to 
patients not taking anti TB drugs.  
Those patients who have had CD4 count of < 200 cells/mm3 were two times 
(AOR=2.13, 95% CI: 1.04, 4.36) more likely to develop anemia than those with CD4 
count ≥ 200 cells/mm3. 
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Table 3 : Bivariate and multivariable analysis of factor associated with anemia 
among adult PLWHA taking ART in Debre Tabor Hospital, North west 
Ethiopia, June 2015 (n=377) ( Table 3) 
*P value < 0.05 on bivariate analysis,    ** P Value <0.05 on multivariable analysis, 
Hosmer and lemeshow test = 0.227    
 
 
 
 Anemia Crude OR 
(95%CI) 
Adjusted OR 
(95% CI ) Variable Yes  No 
Educational Status 
   Unable to read & write        
Read      Read & write 
   Primary school 
   Secondary school 
   College/university 
 
17 (15.3%) 
  5 (20.8%) 
27 (29.3%) 
21 (26.3%) 
17 (24.3%) 
 
94 (84.7%) 
19 (79.1%) 
65 (70.7%) 
59 (73.7%) 
53 (75.7%) 
 
1 
1.46 (0.48,4.43) 
2.29 (1.16,4.55)* 
1.97 (0.96,4.03) 
1.77 (0.84,3.76) 
 
 
Types of ART drugs  
     AZT containing  
     Non AZT containing   
 
46 (41.1%) 
41 (15.5%) 
 
  66 (58.9%) 
224 (84.5%) 
 
3.80 (2.30,6.29)* 
1 
 
2.14 (1.03, 4.57)** 
1 
Anti TB drugs 
      Yes 
      No 
 
22 (62.9%) 
65 (19%) 
 
  13 (37.1%) 
277 (81%) 
 
7.21 (3.45,15.07)* 
1 
 
3.21 (1.19,8.67)** 
1 
 Antibiotic drugs 
      Yes 
      No 
 
85 (23.8%) 
  2 (10%) 
 
 272 (76.2%) 
   18 (90%) 
 
2.81 (0.64,12.37) 
1 
 
 
Duration of ART usage 
     Naïve 
     users 
 
61 (43.6%) 
26 (11%) 
 
  79 (56.4%) 
211 (89%) 
 
6.27 (3.70,10.61)* 
1 
 
3.37 (1.59,7.14)** 
1 
History of OI 
      Yes 
       No 
 
70 (36.6%) 
17 (9.1%) 
 
121 (63.4%) 
169 (90.9%) 
 
5.75 (3.22,10.26)* 
1 
 
 
WHO stage 
     Stage I 
     Stage II 
     Stage III 
     Stage IV 
 
18 (9.6%) 
  5 (7.4%) 
47 (48.5%) 
17 (68%) 
 
169 (91.4%) 
  63 (92.6%) 
  50 (51.5%) 
    8 (32%) 
 
1 
0.75  (0.27,2.09) 
8.83  (4.71,16.54)* 
19.95 (7.56,52.67)* 
 
 
CD4 count(cell/mm3) 
   <200 
   ≥200 
 
58 (46%) 
29 (11.6%) 
 
  68 (54%) 
222 (88.4%) 
 
6.53 (3.87,11.00)* 
1 
 
2.13 (1.04,4.36)** 
1 
WBC count 
    <4000 
    ≥4000 
 
37 (50.7%) 
50 (16.4%) 
 
  36 (49.3%) 
254 (83.6%) 
 
5.22 (3.01,9.05)* 
1 
 
Platelets count  
     <200000 
     ≥200000 
 
34 (44.7%) 
53 (17.6%) 
 
 42 (55.3%) 
248 (82.4%) 
 
3.79(2.20,6.50)* 
1 
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7. Discussion 
Anemia is the most common Hematologic abnormalities in persons with HIV patients  
taking ART (3).This study revealed that  23.1% of HIV/AIDS patients taking ART 
developed anemia and it’s a moderate public health problem(1). This finding was  in  
line  with studies done in India (23%) (6) ,Ghana (24%) (8) Jima university hospital 
Ethiopia (23.1) (16). It was higher than the studies done in Hawassa university hospital 
Ethiopia (12%) (21) and university of Gonder hospital, Ethiopia (11.5%) (11).However, it 
was lower than the studies done in Indonesia (49.6%) (7), Uganda (47.8%) (14), Nigeria 
(57.5%) (9) and Addis Ababa, Ethiopia (33%) (15).This variation  may be due to 
socioeconomic and geographical difference . 
In this study, significant association between duration of ART and anemia was 
observed. Accordingly, ART naïve patients (taking ART ≤ 6 month) were three times 
more likely to develop anemia as compared to patients on ART (taking ART > 6 month). 
This study is in line with studies done in Ghana (8), South Africa (17), Hawassa 
university hospital , Ethiopia (21) and Jima university hospital ,Ethiopia(16). It may be 
due to; ART naïve patients who had advanced disease with low CD4 count, this 
advanced disease decreases bone marrow production (low production of the red blood 
cell in the bone marrow). 
Type of ART drugs was another factor significantly associated with occurrence of 
anemia in this study. As a result, patients who were taking AZT containing regimen 
were two times more likely to develop anemia as compared to patients who were not 
taking AZT containing regimen. This finding is supported by study done in Indonesia (7), 
Iran (22), Namibia (18) and Addis Ababa , Ethiopia (15). This may be due to AZT 
suppresses the bone marrow, this leads to low production of the red blood cell in the 
bone marrow. 
 Anti TB drugs was significantly associated with anemia, hence those patients who took 
anti TB drugs were three times more likely to develop anemia as compared to patients 
who didn’t took anti TB drugs. This finding is supported by study done in India (23) ,It 
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may be due to  both HIV  infection and TB are infiltrate the bone marrow  ,this  bone 
marrow infiltration can cause low production of red blood cell. 
CD4 count was also found to be significantly associated with occurrence of anemia in 
this study. Those patients who have had CD4 count of less than 200cells/mm3 were two 
times more likely as compared to patients who have had CD4 count of 200cells/mm3 or 
more. similar results were reported in studies done in Mexico (24),South Africa 
(17),Namibia (25) and Ethiopia (15).The possible reason may be due to, patients who 
had a low CD4 count (low immunity)  also experience reduction in the number of certain 
other cells in their  blood .This problem may be caused by damage to bone marrow ,this 
bone marrow damaging caused by  HIV infection  per se ,opportunistic infection and 
some drugs, consequently the probability of anemia also increases 
Limitations of the study  
This study has limitation including  
 Being secondary data (Chart review) leading to incompleteness of clinical 
information. 
 Crosse sectional study design didn’t show cause and effect relationship between 
associated factors and anemia. 
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8. Conclusions  
The prevalence of anemia among adult PLWHA patients taking ART was moderate in 
this study. Patients taking ART less than 6 month, Zidovudine containing ART regimen, 
taking anti TB drugs and having CD4 count less than 200 cell/mm3 were the factors that 
increases odds of anemia. 
9. Recommendation  
For Debre Tabor Hospital Health worker 
Recognizing the fact that reducing the prevalence of anemia is to improve survival and 
quality of life and also decrease the chance that HIV infection will progress to AIDS. So 
that early diagnosis and treatment of anemia is recommended for adult PLWHA taking 
ART particularly, ART naïve patients (taking ART ≤ 6 month), taking anti TB drugs, 
Zidovudine containing regimen and CD4 count < 200 cells/mm3. 
For Researcher  
Further longitudinal study needed to discover the cause of anemia and include MCV (it 
used to classify anemia based on morphology) and viral load level   
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11. Annexes 
Annex 1: information sheet  
Research title:  Prevalence of Anemia and its associated factors among adult PLWHA 
patients taking antiretroviral therapy in Debre Tabor Hospital, Northwest Ethiopia 
Introduction 
This information sheet is prepared to explain the research project to responsible bodies 
of the hospital administrator. The research team includes a final year MSC graduate 
student, 3 data collectors and one supervisor from Debre Tabor Hospital, and two 
advisors from UoG. 
Name of Principal Investigator: Hermela Melese (BSC) 
Name of Advisor:  
1. Mr. Molla Mesele (BSc,MSc) 
2. Dr Abilo Tadesse(MD, Associate professor of  medicine) 
Name of the Sponsor: UoG and ANRSHB   
Name of Organization: University of Gondar, College of Medicine and Health 
Sciences, department of internal medicine 
Purpose of the research project: 
The purpose of this research study is to assess the prevalence of anemia and its 
associated factors among adult PLWHA patients taking antiretroviral therapy in Debre 
Tabor Hospital, Amhara National Regional State, Northwest Ethiopia, 2015. 
Procedure: 
This study is using hospital based cross-sectional quantitative study design, through 
used to secondary data. Permission is processed from Debre Tabor hospital 
administration. 
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Risk and/or Discomfort: 
There is no any risk or discomfort since data is extracted from patient’s card. Any 
personal information registered in the chart is not copied and transferred to other 
bodies. Every piece of information was kept confidentially.  
Benefits: There will be benefit for Debre Tabor hospital HIV/AIDS patients taking 
HAART.  
Confidentiality: 
All Personal identifiers & personal information will not take. The information collected 
from this research project will be kept confidential. Information is accessed by the 
researcher only 
Persons to contact: 
This research project is reviewed and approved by the ethical committee of the 
University of Gondar. If you want to know more information you can contact the 
committee through the address below.  
1. Hermela Melese (BSC)  
  Phone number: 0918085427 
  E-mail:Hailu.hermela@yahoo.com 
2. Mr. Mola Mesele (BSc, MSc) 
Phone number: 0920254664 
E-mail: molmesele@gmail.com 
3. Dr Abilo Tadesse (MD, Associate professor of medicine) 
Phone number: 0911405144 
Email address: abilo.tadess@yahoo.com 
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Annex 2: Data compilation checklist 
Patient information checklist   
Name of the Health facility: ____________Identification no.______ 
Chart no-------------------------              
Part 1: Socio demographic factors  
S.No Variables  Response  Remark  
101 Sex 1.Male 
2.Female 
 
102 Age  -------- years   
103 Ethnic group 1.Amhara  
2.Tigre 
3.Oromo 
4.Others,specify ------------ 
 
104 Marital status  1.Single 
2.Married 
3.Divorced 
4.Widowed 
5.Separated 
 
105 Religion 
 
 
1.Ortodox  
 2.Muslim 
3.Protestant 
4.Others,specify ,------------- 
 
106 
 
 
 
Residence 1.Urban 
2.Rural 
 
107 Educational Status 
 
1.illeterate  
2.Read and write  
3.Primary school  
4.Secondary school  
5.Preparatory  school 
6.College/University completed 
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Occupational status 
 
1. Civil servant  
2. Daily laborer 
3. Merchant 
4. Housewife 
5. Retired 
6. Farmer 
7. Student 
8. Un employed 
9. Other 
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Part II: Medication related factors  
S.No Variables  Response  Remark 
201 Type of ART drugs  1.AZT containing regimen 
2.Non AZT containing regimen 
 
202 Anti TB drugs  1.Yes 
2.No 
 
203 
Antibiotic drugs  
1.Yes 
2.No 
 
204 Antifungal drugs 1.Yes 
2.No 
 
205 
Antiviral drugs(other 
than ART) 1.Yes 
2.No 
 
206 
Duration of HAART 
usage 
  
1.Naive  
2.Users  
 
 
 
Part III: Co-morbidity factors  
S.No Variables  Response  Remark  
301 History  of  
Opportunistic infection   
1.Yes 
2.No 
 
Part IV: WHO Stage factors  
S.No Variables  Response  Remark 
401 WHO stage  1.stage I 
2.stage II 
3.stage III 
4.stage IV 
 
 
Part V: Hematologic parameter  
S.No Variables  Response  Remark 
501 CD4 count   
               cell/mm3 
 
 
502 WBC count                cells/mm3 
 
 
503 platelets count                cells/mm3  
594 Hemoglobin level                gm/dl  
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Part VI: Physical measurements 
S.No Variables Response Remark 
601 Height in cm ______cm   
BMI------- 602 Weight in kg               kg  
  
Name of data collector_____________ Signature _________________ 
Name of supervisor _______________ Signature _________________ 
Date of data collection_______ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
32 
 
Annex 3: Declaration    
 
I, the undersigned, clinical tropical infectious disease and HIV medicine student declare 
that this research is my original work in partial fulfillment of the requirement for the 
degree of Master of clinical tropical infectious disease and HIV medicine  
Name________________________________________ 
Signature____________________________________ 
 
 
Place of submission: Department of internal medicine, College of Medicine and Health 
Sciences, University of Gondar 
Date of submission: _______________________________ 
 
This research work has been submitted with my/our approval as university 
advisor/s 
 
Advisors  
Name                                                           Signature                        Date  
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Annex 4. Assurance of the investigator 
The under signed agree to accept responsibility for the scientific, ethical and technical 
conduct of the research project and for provision of required process report as pre terms 
and conditions of research and publication office of the University of Gondar. 
Name of the student - Hermela Melese (BSc) 
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